IFNB1 and atherosclerosis: Furthermore, in a mouse model for atherosclerosis, IFN-β treatment accelerated lesion formation whereas myeloid-specific IFNAR1 deletion resulted in a more favorable atherosclerotic phenotype (34), suggesting a pro-atherogenic feature of type-I IFNs.